• Risedronate Sodium: An Assay-First Guide

  2026-09-10

  Risedronate Sodium is more than a conventional antiresorptive: its FPP synthase inhibitor activity connects mevalonate biology, osteoclast assays, and lung-targeted delivery. This guide translates the latest dendrimer study into practical decisions about controls, dosing, formulation, and interpretation.

• Etomoxir: From FAO Mechanism to Translation

  2026-09-09

  Etomoxir is more than a CPT-1 tool: it is a strategic perturbation for connecting fatty acid oxidation, lipid remodeling, and immune function. This thought-leadership guide examines how to use Etomoxir and R-(+)-Etomoxir responsibly across standardized whole-blood assays, cellular systems, and the experimental autoimmune encephalomyelitis model while managing DGAT-related confounding and translational limitations.

• AT-406 (SM-406): From IAP Biology to Translation

  2026-09-09

  AT-406 (SM-406) offers a mechanistically defined way to study IAP-dependent survival, apoptosis pathway activation in cancer cells, and chemotherapy sensitization. This thought-leadership perspective connects its preclinical oncology evidence with lessons from in vivo CRISPR screening while outlining a disciplined path from assay design to translational decision-making.

• Nanoparticle Uptake in Human Corneal Epithelium

  2026-09-08

  This 2024 study shows that nanoparticle size and surface chemistry jointly influence uptake by human corneal epithelial cells, with energy-dependent endocytosis, macropinocytosis, and caveolae-mediated entry emerging as the main mechanisms. Its in vitro design provides a practical framework for comparing ocular nanoparticle formulations while emphasizing the limits of translating cell uptake directly into clinical delivery.

• WY-14643: From PPARα Biology to Translation

  2026-09-08

  WY-14643, also known as Pirinixic Acid, is more than a standard PPARα agonist. Its value lies in connecting lipid metabolism regulation, endothelial inflammation, insulin sensitivity enhancement, and emerging tumor-microenvironment biology while providing a tractable benchmark for translational study design.

• Carvedilol: Receptor, Vascular, and HCT Evidence

  2026-09-07

  Carvedilol is a dual β-adrenergic receptor antagonist and α1-adrenergic receptor antagonist used in receptor, vascular, oxidative-stress, and transplantation research. Evidence supports receptor blockade, antioxidant activity, inhibition of vascular smooth muscle responses, and a context-dependent risk of delayed hematopoietic recovery after allogeneic transplantation.

• MK-571: Separating LTD4 Signaling from MRP1

  2026-09-07

  MK-571 (L-660,711) is more than a leukotriene receptor probe: its MRP1 activity can reshape how macrophage and pulmonary assays are interpreted. This article presents a two-axis framework for distinguishing cysLT1 signaling from ABCC1-mediated transport and redox protection.

• CDC42 Polarity Controls Intestinal Stem Cell Fate

  2026-09-05

  Zhang et al. show that CDC42-dependent apical–basal polarity regulates the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–epiregulin–EGFR–mTOR cascade. Genetic and pharmacological rescue experiments place epithelial polarity upstream of crypt proliferation, while also showing that restoring cell-number balance does not necessarily restore tissue architecture.

• Gentamycin Sulfate: From Ribosome to Resistance Strategy

  2026-09-04

  Gentamycin Sulfate is more than a broad-spectrum aminoglycoside antibiotic: it is a mechanistically defined perturbation tool for connecting ribosome function, bacterial fitness, and resistance phenotypes. This article outlines how translational researchers can use it alongside contemporary surveillance data to build more informative Gram-negative infection models without confusing research evidence with clinical treatment guidance.

• EdU Imaging Kits (HF594): Practical Workflow

  2026-09-04

  EdU Imaging Kits (HF594) provide a click-chemistry method for measuring S-phase DNA synthesis in cell proliferation assays using fluorescence microscopy or flow cytometry. They are suited to fixed-cell proliferation, genotoxicity, and pharmacodynamic workflows, but EdU signal alone should not be interpreted as proof of completed cell division, viability, or long-term population expansion.

• Halazone Workflows for Water and Nerve Research

  2026-09-03

  Halazone combines rapid oxidative water disinfection with a distinctive electrophysiology use-case: probing sodium-current inactivation in myelinated nerve fibers. This guide translates those findings into practical assay workflows, formulation controls, and troubleshooting decisions for antimicrobial resistance research and membrane physiology.

• MRTFA–KCNMB1 Axis Controls Cancer Cell Stiffness

  2026-09-03

  Gajda et al. identify potassium efflux and the BK-channel auxiliary subunit KCNMB1 as regulators of cancer cell stiffness downstream of MRTFA. Their genetic, biophysical, immunological, and in vivo analyses show that BK-channel activation stiffens cancer cells, improves immune-cell killing, and reduces metastatic colonization.

• Risedronate Sodium in Cell Assays

  2026-09-02

  A scenario-based guide to using Risedronate Sodium (SKU A5293) in viability, proliferation, uptake, and cytotoxicity workflows. It connects FPPS inhibition with practical formulation, concentration-selection, interpretation, and supplier-reliability decisions.

• AZ505: A Selective SMYD2 Inhibitor Workflow

  2026-09-02

  AZ505 enables substrate-competitive interrogation of SMYD2 in biochemical, cellular, fibrosis, and cancer models. This practical guide connects potency and selectivity data with assay design, renal-injury findings, controls, and troubleshooting strategies.

• Cefazedone (Refosporen): From MIC to Translation

  2026-09-01

  A translational framework for connecting Cefazedone mechanism, assay design, bioanalytical validation, and PK/PD interpretation across antibacterial research workflows.

8559 records 1/571 page Next 12345 下5页 Last page